Claims for Patent: 6,451,591

Summary for Patent: 6,451,591

Title:	Device and method for the determination of protein domain boundaries
Abstract:	A method and device to assist in the determination of protein domain boundaries is described. In particular the device is designed to provide a high throughput of proteolytic digestion of proteins to identify domains and their boundaries, for use in protein structure determination, in a manner that is amenable to automation. Proteases are immobilized in a convenient format such as a microtitre plate and preferably arranged in a matrix thereby allowing for simultaneous degradation of a protein by a number of proteases at a number of concentrations.
Inventor(s):	Edwards; Aled (Toronto, Ontario, CA)
Assignee:
Application Number:	09/720,272
Patent Claims:	1. An apparatus for degradation of a protein, said apparatus comprising a plurality of compartments, each compartment containing a quantity of a protease immobilized on a surface in each compartment wherein at least two compartments contain different concentrations of said protease. 2. An apparatus according to claim 1 wherein each compartment containing a quantity of said protease contains a concentration of said protease distinct from the concentration of said protease in every other compartment. 3. An apparatus according to claim 1 wherein at least three concentrations of protease are in said compartments. 4. An apparatus according to claim 3 wherein said plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in said compartments. 5. An apparatus according to claim 1 wherein said matrix contains more than one protease. 6. An apparatus according to claim 5 wherein said matrix is in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis. 7. An apparatus according to claim 1 wherein said protease is selected from the group consisting of aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin. 8. An apparatus according to claim 7 wherein the proteases are trypsin, chymotrypsin, proteinase K or papain. 9. An apparatus according to claim 8 wherein the concentrations of each of the proteases along the first axis in each case is from about 50 .mu.g/mL to about 0.5 .mu.g/mL. 10. An apparatus according to claim 9 wherein the concentration for each of the proteases is about 50 .mu.g/mL in one container of a concentration axis; about 25 .mu.g/mL in a second container of the concentration axis; about 5 .mu.g/mL in a third container of the concentration axis; about 2.5 .mu.g/mL in a fourth container of the concentration axis; about 0.51 .mu.g/mL in a fifth container of the concentration axis; about 0 .mu.g/mL in a sixth container of the concentration axis. 11. An apparatus according to claim 1 wherein the surface upon which said protease is immobilized has been treated with a blocker of surface interaction. 12. An apparatus according to claim 11 wherein the blocker is selected from the group consisting of BSA and beta-octyl glucoside. 13. An apparatus according to claim 1 wherein the surface to which said protease is immobilized is selected from the group consisting of an organic support of material selected from the group consisting of polyesters, polyamides, polyacrylates, polymethacrylates, polyacrylamides, poly(acrylic acid)m, poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins; cellulose; cellulose derivatives; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and an inorganic support material selected from the group consisting of siliceous and nonsiliceous metal oxides. 14. An apparatus according to claim 1 wherein the apparatus may be prepared and stored prior to use. 15. An apparatus according to claim 1 wherein said apparatus is a microtitre plate. 16. An apparatus for degradation of a protein, said apparatus comprising a plurality of compartments, each compartment containing a quantity of a protease in solution in each compartment wherein at least two compartments contain different concentrations of said protease. 17. The apparatus of claim 16, wherein said plurality of compartments forms a matrix in a linear format comprising (i) at least three increasing concentrations of protease in said compartments along a first axis, and (ii) at least two different proteases in said compartments along the second axis that is perpendicular to the first axis.

Details for Patent 6,451,591

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Discure Medical, Llc	CHYMODIACTIN	chymopapain	For Injection	018663	11/10/1982		2018-07-15
Discure Medical, Llc	CHYMODIACTIN	chymopapain	For Injection	018663	08/21/1984		2018-07-15
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2018-07-15